Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Total 13F shares
-
9,852,347
-
Share change
-
+605,672
-
Total reported value
-
$214,616,813
-
Put/Call ratio
-
46%
-
Price per share
-
$21.79
-
Number of holders
-
106
-
Value change
-
+$19,210,937
-
Number of buys
-
54
-
Number of sells
-
42
Institutional Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q3 2025
As of 30 Sep 2025,
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,852,347 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, UBS Group AG, BROWN ADVISORY INC, Lane Generational LLC, TWO SIGMA INVESTMENTS, LP, BOONE CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.